$5.60
0.00 (0%)
Indevus Pharmaceuticals (IDEV.DL)
CAPS Rating:
A biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.
No one has written a Pitch for IDEV.DL stock yet. Tell us why you think IDEV.DL will outperform or underperform the S&P 500.
RSS Headlines
Fool UK
